GuiZhou SanLi Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000040B4
CNY
12.18
0.17 (1.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a fall in Operating Profit of -28.31%, the company declared Very Negative results in Mar 25

  • The company has declared negative results for the last 2 consecutive quarters
  • INTEREST(HY) At CNY 7.78 MM has Grown at 27%
  • OPERATING CASH FLOW(Y) Lowest at CNY 87.38 MM
  • ROCE(HY) Lowest at 16.7%
2

With ROE of 16.66%, it has a expensive valuation with a 3.52 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 5,206 Million (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.67%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

16.66%

stock-summary
Price to Book

3.52

Revenue and Profits:
Net Sales:
289 Million
(Quarterly Results - Jun 2025)
Net Profit:
43 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.84%
0%
-4.84%
6 Months
-1.46%
0%
-1.46%
1 Year
-14.65%
0%
-14.65%
2 Years
-36.89%
0%
-36.89%
3 Years
-30.32%
0%
-30.32%
4 Years
-11.93%
0%
-11.93%
5 Years
-49.73%
0%
-49.73%

GuiZhou SanLi Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.59%
EBIT Growth (5y)
13.17%
EBIT to Interest (avg)
29.90
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.88
Tax Ratio
13.06%
Dividend Payout Ratio
49.87%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.56%
ROE (avg)
15.30%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
3.52
EV to EBIT
21.75
EV to EBITDA
16.93
EV to Capital Employed
2.80
EV to Sales
3.05
PEG Ratio
NA
Dividend Yield
2.67%
ROCE (Latest)
12.89%
ROE (Latest)
16.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -41.24% vs 76.27% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -30.36% vs 31.62% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "289.40",
          "val2": "492.50",
          "chgp": "-41.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.10",
          "val2": "87.80",
          "chgp": "-32.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "4.50",
          "chgp": "-22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "42.90",
          "val2": "61.60",
          "chgp": "-30.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.50%",
          "val2": "139.50%",
          "chgp": "-0.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.81% vs 35.97% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,117.10",
          "val2": "1,618.40",
          "chgp": "30.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "400.50",
          "val2": "307.00",
          "chgp": "30.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.60",
          "val2": "4.20",
          "chgp": "247.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "279.80",
          "val2": "294.90",
          "chgp": "-5.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.30%",
          "val2": "166.50%",
          "chgp": "-1.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
289.40
492.50
-41.24%
Operating Profit (PBDIT) excl Other Income
59.10
87.80
-32.69%
Interest
3.50
4.50
-22.22%
Exceptional Items
0.10
0.00
Consolidate Net Profit
42.90
61.60
-30.36%
Operating Profit Margin (Excl OI)
138.50%
139.50%
-0.10%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -41.24% vs 76.27% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -30.36% vs 31.62% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,117.10
1,618.40
30.81%
Operating Profit (PBDIT) excl Other Income
400.50
307.00
30.46%
Interest
14.60
4.20
247.62%
Exceptional Items
0.10
-0.00
Consolidate Net Profit
279.80
294.90
-5.12%
Operating Profit Margin (Excl OI)
153.30%
166.50%
-1.32%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 30.81% vs 35.97% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023

stock-summaryCompany CV
About GuiZhou SanLi Pharmaceutical Co., Ltd. stock-summary
stock-summary
GuiZhou SanLi Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available